Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01232439 · ClinicalTrials.gov registry record · Phase 1
A Study of Brain Receptor Occupancy in Healthy Subjects
A Phase 1 study, sponsored by Eli Lilly and Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT01232439 is a Phase 1 study that has completed, run by Eli Lilly and Company. The registered enrollment target is 13 participants.
The verdict
NCT01232439, a Phase 1 study, has completed, sponsored by Eli Lilly and Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
To measure the occupancy of brain kappa opioid receptors after single oral doses of LY2456302.
Interventions
- DRUG opioid receptor kappa antagonist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01232439
The ClinicalTrials.gov registry entry for NCT01232439 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which opioid receptor kappa antagonist is the first listed.
NCT01232439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01232439 about?
NCT01232439 is a clinical study titled "A Study of Brain Receptor Occupancy in Healthy Subjects". To measure the occupancy of brain kappa opioid receptors after single oral doses of LY2456302.
What is the current status of trial NCT01232439?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2010-12. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01232439?
The interventions under investigation include: opioid receptor kappa antagonist (DRUG).
Who is sponsoring clinical trial NCT01232439?
This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.